Park Ha Biological Technology Co., Ltd.

PHHNASDAQConsumer Defensive

$0.39

$-0.00(-0.08%)

Market Cap$9960058

P/E Ratio—

52W High$41.49

52W Low$0.331

Avg Volume635K

Open$0.39

Beta-0.02

Overview

Park Ha Biological Technology Co., Ltd. (PHH) Revenue

Annual & quarterly revenue history · segment & region breakdown

PHH · revenue · updated Jun 8, 2026

Core revenue metrics

Trailing 12 months

Park Ha Biological Technology Co., Ltd. trailing twelve-month (TTM) revenue is $0.32B, a decrease of 3.13% year-over-year from $0.00B in FY2024.

TTM revenue

$0.32B

4-quarter sum · USD

YoY growth

-3.13%

vs FY2024 $0.00B

Price / sales

0.03×

mktCap ÷ TTM rev

Revenue per day

$1M

Est. TTM ÷ 365

Revenue / employee

$18529K

17 employees

FY2024

$0.00B

FY2023

$0.00B

5Y CAGR

+-65.0%

Fiscal year end

Dec 31

Currency

USD · GAAP

Filing

10-K / 10-Q

Source: FMP · Park Ha Biological Technology Co., Ltd. SEC filings · GAAPUpdated: 2026-06-08

Revenue trend

2024 – 2002 · Annual

YoY revenue growth %

revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year end	Revenue	Change	Growth
2024-10-31	$0.00B	-$0.00B	-3.13%
2023-10-31	$0.00B	+$0.00B	+28.11%
2022-10-31	$0.00B	+$0.00B	+106.16%
2021-10-31	$0.00B	-$0.46B	-99.80%
2017-12-31	$0.46B	-$0.17B	-26.69%
2016-12-31	$0.62B	-$0.17B	-21.27%
2015-12-31	$0.79B	+$0.15B	+23.63%
2014-12-31	$0.64B	-$2.20B	-77.52%
2013-12-31	$2.84B	+$0.10B	+3.61%
2012-12-31	$2.74B	+$0.53B	+23.89%

PHH revenue by year · PHH revenue history · PHH annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Park Ha Biological Technology Co., Ltd. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Park Ha Biological Technology Co., Ltd. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Park Ha Biological Technology Co., Ltd.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Price history Financial statements Forecast

Frequently asked questions

PHH revenue · 4 questions

PHH's trailing twelve-month (TTM) revenue is $0.32B. That is a decrease of 3.13% year-over-year from $0.00B in FY2024.

PHH revenuePHH annual revenuewhat is PHH revenuePHH TTM revenue

▸ Source: FMP · Park Ha Biological Technology Co., Ltd. SEC filings · GAAP · Park Ha Biological Technology Co., Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026